ISOPP 2019 Interview: Audit of Rapid Infusion of Biosimilar Rituximab
Year:
2019
Type:
Video
Source:
ISOPP
Authors/Presenters:
Calum Polwart

Calum Polwart, County Durham & Darlington NHS Foundation Trust, Durham, UK, discusses his work on a multi-center audit of the rapid infusion of biosimilar rituximab in patients with hematological malignancies. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.

Last updated:
January 9, 2025

Authors/Presenters

Calum Polwart
Consultant Pharmacist
South Tees NHS Foundation trust
United Kingdom
Calum Polwart
Consultant Pharmacist — South Tees NHS Foundation trust
United Kingdom

Would you like to learn more about this member/person? Unlock exclusive insights and content by logging in or signing up for a no-cost membership account today. Join our community to explore further.

Join ISOPP Today!Member Login
More Info

Related Events

International Symposium
-
Novotel London West, London, UK
In recent years we have seen an explosion in new technology and novel drug therapies. In our quest to keep up with new developments it can be easy to lose sight of what is most important – providing high quality pharmaceutical care for our patients. How can we deliver a modern oncology pharmacy service with a human touch?